Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1604 SEK | -1.11% | -.--% | -.--% |
2023 | IRRAS AB(OM:IRRAS) dropped from OMX Nordic All-Share Index | CI |
2023 | IRRAS AB(OM:IRRAS) dropped from OMX Nordic Small Cap Index | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 16.67M | C | ||
+9.07% | 124B | A- | ||
-7.91% | 10.74B | A- | ||
+2.17% | 8.93B | C | ||
+23.48% | 7.61B | C | ||
+32.13% | 5.27B | B+ | ||
+7.84% | 3.42B | C- | ||
-6.94% | 2.86B | B- | ||
-5.07% | 2.23B | - | - | |
-4.22% | 2.13B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- IRRAS Stock
- Ratings IRRAS AB